Résumé
The cell lineage origin of interferon-producing killer dendritic cells (IKDCs) has been challenged since 2006 when the unique capacity of these cells to accumulate in tumors and mediate remarkable antitumor effects was first described.1-4 In this issue of Blood, Guimont-Desrochers et al redefine B220+ NK cells as a novel intermediate in NK-cell differentiation preceding the acquisition of CD27.
langue originale | Anglais |
---|---|
Pages (de - à) | 4345-4346 |
Nombre de pages | 2 |
journal | Blood |
Volume | 119 |
Numéro de publication | 19 |
Les DOIs |
|
état | Publié - 10 mai 2012 |
Modification externe | Oui |